Literature DB >> 1383841

Degradation of myelin basic protein by a membrane-associated metalloprotease: neural distribution of the enzyme.

A Chantry1, N Gregson, P Glynn.   

Abstract

A metalloprotease activity associated with myelin membrane preparations degrades myelin basic protein (MBP), generating a characteristic fragment designated peptide C (MBP 74-170). Using an immunoblotting assay, peptide C-generating activity was detected in mammalian, avian, reptilian, and amphibian brains. The activity was present in rat brain as early as postnatal day 1 and also in adult rat peripheral nerve. Immunohistochemistry with a monoclonal antibody to the purified enzyme revealed that the metalloprotease was present in oligodendrocytes of optic nerve, of both white and grey matter of spinal cord, and also in the cytoplasm of both myelinating and nonmyelinating Schwann cells of peripheral nerve.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383841     DOI: 10.1007/bf00993261

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  8 in total

1.  A novel metalloproteinase originally isolated from brain myelin membranes is present in many tissues.

Authors:  A Chantry; P Glynn
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

2.  Quantitative electroimmunoblotting study of the calcium-activated neutral protease in human myelin.

Authors:  N Kerlero de Rosbo; P R Carnegie; C C Bernard
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

3.  Metalloendoprotease cleavage of 18.2- and 14.1-kilodalton basic proteins dissociating from rodent myelin membranes generates 10.0- and 5.9-kilodalton C-terminal fragments.

Authors:  A Chantry; C Earl; N Groome; P Glynn
Journal:  J Neurochem       Date:  1988-03       Impact factor: 5.372

4.  Myelination in rat brain: method of myelin isolation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

5.  Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS.

Authors:  N L Banik; W W McAlhaney; E L Hogan
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

6.  A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization.

Authors:  A Chantry; N A Gregson; P Glynn
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

7.  A new epitope on human myelin basic protein arising from cleavage by a metalloendoprotease associated with brain myelin membranes.

Authors:  N Groome; A Chantry; C Earl; J Newcombe; J Keen; J Findlay; P Glynn
Journal:  J Neuroimmunol       Date:  1988-08       Impact factor: 3.478

8.  Basic protein dissociating from myelin membranes at physiological ionic strength and pH is cleaved into three major fragments.

Authors:  P Glynn; A Chantry; N Groome; M L Cuzner
Journal:  J Neurochem       Date:  1987-03       Impact factor: 5.372

  8 in total
  4 in total

1.  Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine.

Authors:  K Norga; L Paemen; S Masure; C Dillen; H Heremans; A Billiau; H Carton; L Cuzner; T Olsson; J Van Damme
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

2.  Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.

Authors:  Mallory Gough; Catherine Parr-Sturgess; Edward Parkin
Journal:  Biochem Res Int       Date:  2010-09-30

3.  Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan.

Authors:  J Zuo; T A Ferguson; Y J Hernandez; W G Stetler-Stevenson; D Muir
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 4.  Metalloproteinases in biology and pathology of the nervous system.

Authors:  V W Yong; C Power; P Forsyth; D R Edwards
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.